|
Screening (oncology)
Citations 1-10 of 51 total displayed.
|
Most recent content
(1 Aug 2009):
|
-
Therapeutics
Annual screening for prostate cancer did not reduce mortality from prostate cancer
- Steven E Canfield
Evid. Based Med. 2009; 14: 104-105.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Therapeutics
Periodic screening with prostate-specific antigen testing reduced mortality from prostate cancer
-
Evid. Based Med. 2009; 14: 105.
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
Past content
(since Jan 2000):
|
-
Prognosis
Review: 1-year risk of previously undiagnosed cancer is 6.3% in patients with newly diagnosed venous thromboembolism
- Arnaud Perrier
Evid. Based Med. 2009; 14: 57.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Therapeutics
Review: faecal occult blood test screening reduces risk of colorectal cancer mortality
- Richard FA Logan
Evid. Based Med. 2009; 14: 15.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Prognosis
Excess mortality after HIV seroconversion has greatly decreased in the past 10 years
- Richard D Moore
Evid. Based Med. 2009; 14: 23.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Clinical prediction guide
The Splenoportal Index accurately predicted the presence of oesophageal varices in compensated cirrhosis
- Jürg Reichen
Evid. Based Med. 2009; 14: 27.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Therapeutics
Review: little high-quality evidence is available regarding treatments for localised prostate cancer
- Richard M Hoffman
Evid. Based Med. 2008; 13: 139.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Therapeutics
Risk of cancer was still increased over 2 years after stopping hormone therapy
- Angela M Cheung
Evid. Based Med. 2008; 13: 142.
[Extract]
[Full text]
[PDF]
[Request Permissions]
-
Therapeutics
Review: individual DMARDs have similar efficacy for RA, but combination therapy improves response
- Bruce M Rothschild
Evid. Based Med. 2008; 13: 76.
[Extract]
[Full text]
[PDF]
[Request Permissions]
[ web only appendix ]
-
Therapeutics
Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women for at least 3 years
- Joy Melnikow
Evid. Based Med. 2007; 12: 168.
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
Show
Screening (oncology)
collections from
other journals.